<small lang="KibUcq6"></small> Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site VSports app下载. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

. 2020 Sep 1:152:105450.
doi: 10.1016/j.ejps.2020.105450. Epub 2020 Jul 2.

Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis

Affiliations

Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis (V体育ios版)

Xiaotian Xu et al. Eur J Pharm Sci. .

"V体育2025版" Abstract

Recent studies have revealed the critical roles of ferroptosis in different physiological and pathological processes, however, its effects on the progression of colorectal cancer stem cells (CSCs) are still unclear VSports手机版. Here, we found that colorectal CSCs exhibited a remarkably lower level of reactive oxygen species (ROS), a higher level of cysteine, glutathione and SLC7A11 compared to colorectal cancer cells. Knockout of SLC7A11 increased the ROS level and reduced the levels of cysteine and glutathione, subsequently attenuating the viability of colorectal CSCs. Erastin, an inhibitor of SLC7A11, was found to hold a remarkably stronger cytotoxic effect on colorectal CSCs via in vitro and in vivo experiments. Finally, it was found that Erastin attenuated the chemoresistance of colorectal CSCs. This work indicates that colorectal CSCs are more sensitive to ferroptosis, which could be targeted to attenuate colorectal cancer progression and chemoresistance. .

Keywords: Cancer stem cell; Chemoresistance; Colorectal cancer; Erastin; Ferroptosis; SLC7A11 V体育安卓版. .

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests The authors declare no conflict of interest.

Substances